ATE118168T1 - Verhütung der synovialischen adhäsion. - Google Patents

Verhütung der synovialischen adhäsion.

Info

Publication number
ATE118168T1
ATE118168T1 AT92901765T AT92901765T ATE118168T1 AT E118168 T1 ATE118168 T1 AT E118168T1 AT 92901765 T AT92901765 T AT 92901765T AT 92901765 T AT92901765 T AT 92901765T AT E118168 T1 ATE118168 T1 AT E118168T1
Authority
AT
Austria
Prior art keywords
synovial
adhesion
prevention
adhesions
intercalated
Prior art date
Application number
AT92901765T
Other languages
English (en)
Inventor
Larry J Moore
Jill Adler-Moore
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Application granted granted Critical
Publication of ATE118168T1 publication Critical patent/ATE118168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Revetment (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92901765T 1990-12-03 1991-12-03 Verhütung der synovialischen adhäsion. ATE118168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62162590A 1990-12-03 1990-12-03

Publications (1)

Publication Number Publication Date
ATE118168T1 true ATE118168T1 (de) 1995-02-15

Family

ID=24490933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901765T ATE118168T1 (de) 1990-12-03 1991-12-03 Verhütung der synovialischen adhäsion.

Country Status (11)

Country Link
US (1) US5411743A (de)
EP (1) EP0560900B1 (de)
JP (1) JPH06507882A (de)
AT (1) ATE118168T1 (de)
AU (1) AU664359B2 (de)
CA (1) CA2099588C (de)
DE (1) DE69107309T2 (de)
DK (1) DK0560900T3 (de)
ES (1) ES2071481T3 (de)
GR (1) GR3015663T3 (de)
WO (1) WO1992009268A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US20040127884A1 (en) * 1994-12-12 2004-07-01 Omeros Corporation Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
BR9509985A (pt) 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US6413961B1 (en) * 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
JP2004135177A (ja) 2002-10-11 2004-04-30 Sharp Corp 携帯電話機
ES2330295B1 (es) 2008-06-06 2010-09-23 Laboratorios Alcala Farma, Sl Formulacion topica de ibuprofeno.
CN103260702B (zh) * 2010-10-28 2018-07-27 帕西拉制药有限公司 非甾体类抗炎药的缓释制剂
CN109983013A (zh) 2016-11-18 2019-07-05 帕西拉制药有限公司 美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
JPH0798755B2 (ja) * 1985-11-27 1995-10-25 エチコン・インコ−ポレ−テツド 局所的投与により術後の癒着形成を抑制するための組成物
IN166447B (de) * 1985-11-27 1990-05-12 Ethicon Inc
DE3778972D1 (de) * 1986-06-12 1992-06-17 Liposome Co Inc Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
GB2217596A (en) * 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
WO1991016920A1 (en) * 1990-05-07 1991-11-14 Vical, Inc. Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
EP0560900B1 (de) 1995-02-08
JPH06507882A (ja) 1994-09-08
US5411743A (en) 1995-05-02
ES2071481T3 (es) 1995-06-16
AU664359B2 (en) 1995-11-16
DE69107309T2 (de) 1995-06-08
DK0560900T3 (da) 1995-05-08
DE69107309D1 (de) 1995-03-23
AU9127991A (en) 1992-06-25
WO1992009268A1 (en) 1992-06-11
EP0560900A1 (de) 1993-09-22
GR3015663T3 (en) 1995-07-31
CA2099588A1 (en) 1992-06-04
CA2099588C (en) 2003-04-15

Similar Documents

Publication Publication Date Title
NO863115D0 (no) Medikament-utleveringsutstyr som forhindrer lokal og systemisk giftighet.
DE69324988D1 (de) Überprüfung des Sprechers
IL106927A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
DE69621021D1 (de) Inhibitoren der plättchenaggregation
FI922102A0 (fi) Resonaattorirakenne
FR2636532B1 (fr) Compositions pharmaceutiques
NO930677L (no) Farmasoeytiske forbindelser
FI945434L (fi) 4-markatpoasetyyliamino/2/bentsatsepinoni (3) johdannaisia ja niiden käyttö enkefalinaasi-inhibiittoreina
KR860005655A (ko) 연속 토출 디스펜서
FI923114A0 (fi) Turvalaitejärjestely
DE69107309D1 (de) Verhütung der synovialischen adhäsion.
IT8422142A0 (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
FI952709A7 (fi) 1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina
DE69328098D1 (de) Lösliche derivate des complement type-rezeptors (cr1)
GR1000631B (el) Μεθοδος παρασκευης υποκατεστημενων βενζαμιδιων φαρμακολογικως δραστικων.
FI943100L (fi) Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina
DE68904263D1 (de) Vakuumpumpe der schraubenbauart.
FI953106A7 (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
GR900100109A (el) Διουρητικοι παραγοντες κυκλοαλκυλο-υποκατεστημενης γλουταραμιδης.
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
FI842835A0 (fi) Saosom anti-inflammatoriska och analgetiska aemnen anvaendbara 9-antryloxiaminoalkaner och dessa beroerande foereningar.
DE69319073D1 (de) Formverbindung zur Entladung statischer Elektrizität
ITMI921865A0 (it) Glicerofosfoderivati farmacologicamente attivi
DE69330280D1 (de) Immuntherapeutika gegen hiv
IT1230930B (it) Derivati imidazolici ad azione inibente l'enzima trombossano sintetasi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time